Chenglong Liu
- Co-authors
- Di ZhuAlbrecht von BrunnYunbin ZhangMing ChenZhongwei ZhaoJiansong JiMengxuan YangJingjing Song
- Topics
- Cancer Immunotherapy and Biomarkers (5 papers)Wnt/β-catenin signaling in development and cancer (4 papers)Peptidase Inhibition and Analysis (3 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- SHILAP Revista de lepidopterologíaChemical Engineering JournalJournal of Medicinal Chemistry
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Chenglong Liu
13 papers receiving 357 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 178
- Oncology 150
- Immunology 109
- Cancer Research 90
- Pulmonary and Respiratory Medicine 58
Countries citing papers authored by Chenglong Liu
This map shows the geographic impact of Chenglong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglong Liu more than expected).
Fields of papers citing papers by Chenglong Liu
This network shows the impact of papers produced by Chenglong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglong Liu. The network helps show where Chenglong Liu may publish in the future.
Co-authorship network of co-authors of Chenglong Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Chenglong Liu. A scholar is included among the top collaborators of Chenglong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenglong Liu. Chenglong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | 7 | |
| 5 | 33 | |
| 6 | 7 | |
| 7 | 8 | |
| 8 | 28 | |
| 9 | 16 | |
| 10 | 5 | |
| 11 | 17 | |
| 12 | 64 | |
| 13 | 37 | |
| 14 | 129 |
About Chenglong Liu
Chenglong Liu is a scholar working on Oncology, Immunology and Endocrine and Autonomic Systems, having authored 14 papers that have together received 358 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Wnt/β-catenin signaling in development and cancer (4 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (90 citations), Oncology (150 citations) and Immunology (109 citations). Chenglong Liu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Di Zhu, Albrecht von Brunn, Yunbin Zhang, Ming Chen, Zhongwei Zhao, Jiansong Ji, Mengxuan Yang, Jingjing Song, Kohichi Takada and Lian Shen. Their work appears in journals such as SHILAP Revista de lepidopterología, Chemical Engineering Journal and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.